Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Filimonov, Viktor Borisovich
NCT04780672: Clinical Study in the Treatment of Patients With COVID-19	Recruiting	3	330	RoW	Molixan, Inosine glycyl-cysteinyl-glutamate disodium, Placebo, Sodium chloride	Pharma VAM	COVID-19	05/22	09/22
NCT04842435: Clinical Study in the Treatment of Patients With Moderate Course of COVID-19	Recruiting	2/3	376	RoW	COVID-globulin, Anti-coronavirus human immunoglobulin, Placebo, 0.9% NaCl solution	Microgen	COVID-19	09/21	10/21

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Filimonov, Viktor Borisovich
NCT04780672: Clinical Study in the Treatment of Patients With COVID-19	Recruiting	3	330	RoW	Molixan, Inosine glycyl-cysteinyl-glutamate disodium, Placebo, Sodium chloride	Pharma VAM	COVID-19	05/22	09/22
NCT04842435: Clinical Study in the Treatment of Patients With Moderate Course of COVID-19	Recruiting	2/3	376	RoW	COVID-globulin, Anti-coronavirus human immunoglobulin, Placebo, 0.9% NaCl solution	Microgen	COVID-19	09/21	10/21